Show simple item record

Evaluation of QuantiFERON-TB Gold Plus for Predicting Incident Tuberculosis among Recent Contacts: A Prospective Cohort Study.

dc.contributor.authorGupta, RK
dc.contributor.authorKunst, H
dc.contributor.authorLipman, M
dc.contributor.authorNoursadeghi, M
dc.contributor.authorJackson, C
dc.contributor.authorSouthern, J
dc.contributor.authorImran, A
dc.contributor.authorLozewicz, S
dc.contributor.authorAbubakar, I
dc.date.accessioned2020-07-13T13:56:18Z
dc.date.available2020-07-13T13:56:18Z
dc.date.issued2020-02-21
dc.identifier.citationDavide Fiore Bavaro, Deborah Fiordelisi, Gioacchino Angarano, Laura Monno, Annalisa Saracino. (2020) Targeted therapies for autoimmune/idiopathic nonmalignant diseases: risk and management of opportunistic infections. Expert Opinion on Drug Safety 6, 1-25.en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/65633
dc.languageeng
dc.language.isoenen_US
dc.publisherAmerican Thoracic Societyen_US
dc.relation.ispartofAnn Am Thorac Soc
dc.rightsCC BY
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.titleEvaluation of QuantiFERON-TB Gold Plus for Predicting Incident Tuberculosis among Recent Contacts: A Prospective Cohort Study.en_US
dc.typeArticleen_US
dc.identifier.doi10.1513/AnnalsATS.201905-407RL
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/32083944en_US
pubs.notesNot knownen_US
pubs.publication-statusPublished onlineen_US
rioxxterms.funderDefault funderen_US
rioxxterms.identifier.projectDefault projecten_US
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0/en_US


Files in this item

Thumbnail
Name:
Gupta Evaluation of QuantiFERON-TB ...
Size:
439.1Kb
Format:
application/
Description:
Published version
View/Open
Thumbnail
Name:
license_rdf
Size:
914bytes
Format:
application/rdf+xml
View/Open

This item appears in the following Collection(s)

Show simple item record

CC BY
Except where otherwise noted, this item's license is described as CC BY